Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 80

1.

Methotrexate for Prevention of Cardiovascular Events.

Huang Y, Chan AW, Shear NH.

N Engl J Med. 2019 Jun 6;380(23):2277. doi: 10.1056/NEJMc1905061. No abstract available.

PMID:
31167067
2.

Incidence and Risk Factors of Keratinocyte Carcinoma After First Solid Organ Transplant in Ontario, Canada.

Park CK, Fung K, Austin PC, Kim SJ, Singer LG, Baxter NN, Rochon PA, Chan AW.

JAMA Dermatol. 2019 May 22. doi: 10.1001/jamadermatol.2019.0692. [Epub ahead of print]

PMID:
31116351
3.

Improving outcome reporting in clinical trial reports and protocols: study protocol for the Instrument for reporting Planned Endpoints in Clinical Trials (InsPECT).

Butcher NJ, Monsour A, Mew EJ, Szatmari P, Pierro A, Kelly LE, Farid-Kapadia M, Chee-A-Tow A, Saeed L, Monga S, Ungar W, Terwee CB, Vohra S, Fergusson D, Askie LM, Williamson PR, Chan AW, Moher D, Offringa M.

Trials. 2019 Mar 6;20(1):161. doi: 10.1186/s13063-019-3248-0.

4.

Guidance for reporting outcomes in clinical trials: scoping review protocol.

Butcher NJ, Mew EJ, Saeed L, Monsour A, Chee-A-Tow A, Chan AW, Moher D, Offringa M.

BMJ Open. 2019 Feb 19;9(2):e023001. doi: 10.1136/bmjopen-2018-023001.

5.

Skin cancer screening after solid organ transplantation: Survey of practices in Canada.

Lam K, Coomes EA, Nantel-Battista M, Kitchen J, Chan AW.

Am J Transplant. 2019 Jun;19(6):1792-1797. doi: 10.1111/ajt.15224. Epub 2019 Jan 23.

PMID:
30604583
6.

Standard Protocol Items for Clinical Trials with Traditional Chinese Medicine 2018: Recommendations, Explanation and Elaboration (SPIRIT-TCM Extension 2018).

Dai L, Cheng CW, Tian R, Zhong LL, Li YP, Lyu AP, Chan AW, Shang HC, Bian ZX.

Chin J Integr Med. 2019 Jan;25(1):71-79. doi: 10.1007/s11655-018-2999-x. Epub 2018 Nov 27.

PMID:
30484022
7.

Transparency in clinical trial reporting.

Rochon PA, Stall NM, Savage RD, Chan AW.

BMJ. 2018 Oct 9;363:k4224. doi: 10.1136/bmj.k4224. No abstract available.

PMID:
30301724
8.

Outcome reporting bias in trials: a methodological approach for assessment and adjustment in systematic reviews.

Kirkham JJ, Altman DG, Chan AW, Gamble C, Dwan KM, Williamson PR.

BMJ. 2018 Sep 28;362:k3802. doi: 10.1136/bmj.k3802. No abstract available.

9.

Improved keratinocyte carcinoma outcomes with annual dermatology assessment after solid organ transplantation: Population-based cohort study.

Chan AW, Fung K, Austin PC, Kim SJ, Singer LG, Baxter NN, Alhusayen R, Rochon PA.

Am J Transplant. 2019 Feb;19(2):522-531. doi: 10.1111/ajt.14966. Epub 2018 Jul 6.

PMID:
29900669
10.

SPIRIT promotes protocol sharing.

Chan AW, Moher D, Altman DG.

Lancet Psychiatry. 2018 May;5(5):390-391. doi: 10.1016/S2215-0366(18)30125-1. Epub 2018 Mar 29. No abstract available.

PMID:
29606566
11.

Treatment for Lentigo Maligna of the Head and Neck: Survey of Practices in Ontario, Canada.

Liu A, Botkin A, Murray C, Goldstein D, Hofer SOP, Solish N, Kitchen J, Chan AW.

Dermatol Surg. 2018 Jul;44(7):918-923. doi: 10.1097/DSS.0000000000001498.

PMID:
29543619
12.

Promoting public access to clinical trial protocols: challenges and recommendations.

Chan AW, Hróbjartsson A.

Trials. 2018 Feb 17;19(1):116. doi: 10.1186/s13063-018-2510-1.

13.

Guidelines for Inclusion of Patient-Reported Outcomes in Clinical Trial Protocols: The SPIRIT-PRO Extension.

Calvert M, Kyte D, Mercieca-Bebber R, Slade A, Chan AW, King MT; the SPIRIT-PRO Group, Hunn A, Bottomley A, Regnault A, Chan AW, Ells C, O'Connor D, Revicki D, Patrick D, Altman D, Basch E, Velikova G, Price G, Draper H, Blazeby J, Scott J, Coast J, Norquist J, Brown J, Haywood K, Johnson LL, Campbell L, Frank L, von Hildebrand M, Brundage M, Palmer M, Kluetz P, Stephens R, Golub RM, Mitchell S, Groves T.

JAMA. 2018 Feb 6;319(5):483-494. doi: 10.1001/jama.2017.21903.

14.

Search for unpublished data by systematic reviewers: an audit.

Ziai H, Zhang R, Chan AW, Persaud N.

BMJ Open. 2017 Oct 6;7(10):e017737. doi: 10.1136/bmjopen-2017-017737. Review.

15.

Association of Trial Registration With Reporting of Primary Outcomes in Protocols and Publications.

Chan AW, Pello A, Kitchen J, Axentiev A, Virtanen JI, Liu A, Hemminki E.

JAMA. 2017 Nov 7;318(17):1709-1711. doi: 10.1001/jama.2017.13001. No abstract available.

16.

Systematic Review of Sex-Specific Reporting of Data: Cholinesterase Inhibitor Example.

Mehta N, Rodrigues C, Lamba M, Wu W, Bronskill SE, Herrmann N, Gill SS, Chan AW, Mason R, Day S, Gurwitz JH, Rochon PA.

J Am Geriatr Soc. 2017 Oct;65(10):2213-2219. doi: 10.1111/jgs.15020. Epub 2017 Aug 18. Review.

PMID:
28832937
17.

What Is Known About the Psychodermatology Clinic Model of Care? A Systematic Scoping Review.

Zhou S, Mukovozov I, Chan AW.

J Cutan Med Surg. 2018 Jan/Feb;22(1):44-50. doi: 10.1177/1203475417719045. Epub 2017 Jul 10.

PMID:
28689431
18.

Protocol for a systematic review of N-of-1 trial protocol guidelines and protocol reporting guidelines.

Porcino AJ, Punja S, Chan AW, Kravitz R, Orkin A, Ravaud P, Schmid CH, Vohra S.

Syst Rev. 2017 Jul 6;6(1):132. doi: 10.1186/s13643-017-0525-4.

19.

Leflunomide for the treatment of trichodysplasia spinulosa in a liver transplant recipient.

Kassar R, Chang J, Chan AW, Lilly LB, Al Habeeb A, Rotstein C.

Transpl Infect Dis. 2017 Aug;19(4). doi: 10.1111/tid.12702. Epub 2017 May 15.

PMID:
28326649
20.

A randomized-controlled trial of nabilone for the prevention of acute postoperative nausea and vomiting in elective surgery.

Levin DN, Dulberg Z, Chan AW, Hare GM, Mazer CD, Hong A.

Can J Anaesth. 2017 Apr;64(4):385-395. doi: 10.1007/s12630-017-0814-3. Epub 2017 Feb 3.

PMID:
28160217
21.

Research Techniques Made Simple: Assessing Risk of Bias in Systematic Reviews.

Drucker AM, Fleming P, Chan AW.

J Invest Dermatol. 2016 Nov;136(11):e109-e114. doi: 10.1016/j.jid.2016.08.021. Review.

22.

ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions.

Sterne JA, Hernán MA, Reeves BC, Savović J, Berkman ND, Viswanathan M, Henry D, Altman DG, Ansari MT, Boutron I, Carpenter JR, Chan AW, Churchill R, Deeks JJ, Hróbjartsson A, Kirkham J, Jüni P, Loke YK, Pigott TD, Ramsay CR, Regidor D, Rothstein HR, Sandhu L, Santaguida PL, Schünemann HJ, Shea B, Shrier I, Tugwell P, Turner L, Valentine JC, Waddington H, Waters E, Wells GA, Whiting PF, Higgins JP.

BMJ. 2016 Oct 12;355:i4919. doi: 10.1136/bmj.i4919. No abstract available.

23.

Application of Recursive Partitioning to Derive and Validate a Claims-Based Algorithm for Identifying Keratinocyte Carcinoma (Nonmelanoma Skin Cancer).

Chan AW, Fung K, Tran JM, Kitchen J, Austin PC, Weinstock MA, Rochon PA.

JAMA Dermatol. 2016 Oct 1;152(10):1122-1127. doi: 10.1001/jamadermatol.2016.2609.

PMID:
27533718
24.

Honorary and ghost authorship in reports of randomised clinical trials in oncology.

Vera-Badillo FE, Napoleone M, Krzyzanowska MK, Alibhai SM, Chan AW, Ocana A, Templeton AJ, Seruga B, Amir E, Tannock IF.

Eur J Cancer. 2016 Oct;66:1-8. doi: 10.1016/j.ejca.2016.06.023. Epub 2016 Aug 6.

PMID:
27500368
25.

SPIRIT 2013 Statement: defining standard protocol items for clinical trials.

Chan AW, Tetzlaff JM, Altman DG, Laupacis A, Gøtzsche PC, Krle A-Jerić K, Hrobjartsson A, Mann H, Dickersin K, Berlin JA, Dore CJ, Parulekar WR, Summerskill WS, Groves T, Schulz KF, Sox HC, Rockhold FW, Rennie D, Moher D.

Rev Panam Salud Publica. 2015 Dec;38(6):506-14.

26.

Bias in reporting of randomised clinical trials in oncology.

Vera-Badillo FE, Napoleone M, Krzyzanowska MK, Alibhai SM, Chan AW, Ocana A, Seruga B, Templeton AJ, Amir E, Tannock IF.

Eur J Cancer. 2016 Jul;61:29-35. doi: 10.1016/j.ejca.2016.03.066. Epub 2016 May 3.

PMID:
27151552
27.

Skin Cancer Prevention and Treatment in Solid Organ Transplant Patients: A Survey of the International Transplant Skin Cancer Collaborative.

Wang A, Chan AW, Aasi S, Lee C, Krathen M.

Dermatol Surg. 2016 May;42(5):682-3. doi: 10.1097/DSS.0000000000000668. No abstract available.

PMID:
27045747
28.

Comprehensive capture of cutaneous melanoma by the Ontario Cancer Registry: validation study using community pathology reports.

Tran JM, Schwartz R, Fung K, Rochon P, Chan AW.

Cancer Causes Control. 2016 Jan;27(1):137-42. doi: 10.1007/s10552-015-0690-5. Epub 2015 Nov 4.

PMID:
26537120
29.

Interventions for melanoma in situ, including lentigo maligna.

Tzellos T, Kyrgidis A, Mocellin S, Chan AW, Pilati P, Apalla Z.

Cochrane Database Syst Rev. 2014 Dec 19;(12):CD010308. doi: 10.1002/14651858.CD010308.pub2. Review.

PMID:
25526608
30.

Antibody induction versus placebo, no induction, or another type of antibody induction for liver transplant recipients.

Penninga L, Wettergren A, Wilson CH, Chan AW, Steinbrüchel DA, Gluud C.

Cochrane Database Syst Rev. 2014 Jun 5;(6):CD010253. doi: 10.1002/14651858.CD010253.pub2. Review.

PMID:
24901467
31.

Antibody induction versus corticosteroid induction for liver transplant recipients.

Penninga L, Wettergren A, Wilson CH, Chan AW, Steinbrüchel DA, Gluud C.

Cochrane Database Syst Rev. 2014 May 31;(5):CD010252. doi: 10.1002/14651858.CD010252.pub2. Review.

PMID:
24880007
32.

Systematic review of melanoma incidence and prognosis in solid organ transplant recipients.

Dahlke E, Murray CA, Kitchen J, Chan AW.

Transplant Res. 2014 May 6;3:10. doi: 10.1186/2047-1440-3-10. eCollection 2014. Review.

33.

Research: increasing value, reducing waste - Authors' reply.

Glasziou P, Macleod M, Chalmers I, Ioannidis JP, Al-Shahi Salman R, Chan AW.

Lancet. 2014 Mar 29;383(9923):1126-7. doi: 10.1016/S0140-6736(14)60563-8. No abstract available.

PMID:
24679627
34.

Better reporting of interventions: template for intervention description and replication (TIDieR) checklist and guide.

Hoffmann TC, Glasziou PP, Boutron I, Milne R, Perera R, Moher D, Altman DG, Barbour V, Macdonald H, Johnston M, Lamb SE, Dixon-Woods M, McCulloch P, Wyatt JC, Chan AW, Michie S.

BMJ. 2014 Mar 7;348:g1687. doi: 10.1136/bmj.g1687.

PMID:
24609605
35.

Making prospective registration of observational research a reality.

Dal-Ré R, Ioannidis JP, Bracken MB, Buffler PA, Chan AW, Franco EL, La Vecchia C, Weiderpass E.

Sci Transl Med. 2014 Feb 19;6(224):224cm1. doi: 10.1126/scitranslmed.3007513.

36.

Increasing value and reducing waste: addressing inaccessible research.

Chan AW, Song F, Vickers A, Jefferson T, Dickersin K, Gøtzsche PC, Krumholz HM, Ghersi D, van der Worp HB.

Lancet. 2014 Jan 18;383(9913):257-66. doi: 10.1016/S0140-6736(13)62296-5. Epub 2014 Jan 8.

37.

Biomedical research: increasing value, reducing waste.

Macleod MR, Michie S, Roberts I, Dirnagl U, Chalmers I, Ioannidis JP, Al-Shahi Salman R, Chan AW, Glasziou P.

Lancet. 2014 Jan 11;383(9912):101-4. doi: 10.1016/S0140-6736(13)62329-6. Epub 2014 Jan 8. No abstract available.

PMID:
24411643
38.

Use of trial register information during the peer review process.

Mathieu S, Chan AW, Ravaud P.

PLoS One. 2013 Apr 10;8(4):e59910. doi: 10.1371/journal.pone.0059910. Print 2013.

39.

SPIRIT 2013: new guidance for content of clinical trial protocols.

Chan AW, Tetzlaff JM, Altman DG, Dickersin K, Moher D.

Lancet. 2013 Jan 12;381(9861):91-2. doi: 10.1016/S0140-6736(12)62160-6. Epub 2013 Jan 8. No abstract available.

PMID:
23305999
40.

SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials.

Chan AW, Tetzlaff JM, Gøtzsche PC, Altman DG, Mann H, Berlin JA, Dickersin K, Hróbjartsson A, Schulz KF, Parulekar WR, Krleza-Jeric K, Laupacis A, Moher D.

BMJ. 2013 Jan 8;346:e7586. doi: 10.1136/bmj.e7586.

41.

SPIRIT 2013 statement: defining standard protocol items for clinical trials.

Chan AW, Tetzlaff JM, Altman DG, Laupacis A, Gøtzsche PC, Krleža-Jerić K, Hróbjartsson A, Mann H, Dickersin K, Berlin JA, Doré CJ, Parulekar WR, Summerskill WS, Groves T, Schulz KF, Sox HC, Rockhold FW, Rennie D, Moher D.

Ann Intern Med. 2013 Feb 5;158(3):200-7. doi: 10.7326/0003-4819-158-3-201302050-00583.

42.

Guidelines for randomized clinical trial protocol content: a systematic review.

Tetzlaff JM, Chan AW, Kitchen J, Sampson M, Tricco AC, Moher D.

Syst Rev. 2012 Sep 24;1:43. doi: 10.1186/2046-4053-1-43.

43.

Developing a guideline for clinical trial protocol content: Delphi consensus survey.

Tetzlaff JM, Moher D, Chan AW.

Trials. 2012 Sep 24;13:176. doi: 10.1186/1745-6215-13-176.

44.

Standard 2: containing risk of bias.

Hartling L, Hamm M, Klassen T, Chan AW, Meremikwu M, Moyer V, Scott S, Moher D, Offringa M; StaR Child Health Group.

Pediatrics. 2012 Jun;129 Suppl 3:S124-31. doi: 10.1542/peds.2012-0055E. Review. No abstract available.

PMID:
22661758
45.

Calcineurin inhibitor minimisation versus continuation of calcineurin inhibitor treatment for liver transplant recipients.

Penninga L, Wettergren A, Chan AW, Steinbrüchel DA, Gluud C.

Cochrane Database Syst Rev. 2012 Mar 14;(3):CD008852. doi: 10.1002/14651858.CD008852.pub2. Review.

PMID:
22419339
46.

Out of sight but not out of mind: how to search for unpublished clinical trial evidence.

Chan AW.

BMJ. 2012 Jan 3;344:d8013. doi: 10.1136/bmj.d8013. Review. No abstract available.

PMID:
22214892
47.

Cricoid pressure provides incomplete esophageal occlusion associated with lateral deviation: a magnetic resonance imaging study.

Boet S, Duttchen K, Chan J, Chan AW, Morrish W, Ferland A, Hare GM, Hong AP.

J Emerg Med. 2012 May;42(5):606-11. doi: 10.1016/j.jemermed.2011.05.014. Epub 2011 Jun 12.

PMID:
21669510
48.

Access to clinical trial data.

Chan AW.

BMJ. 2011 Jan 12;342:d80. doi: 10.1136/bmj.d80. No abstract available.

PMID:
21228020
49.

Investigator experiences with financial conflicts of interest in clinical trials.

Rochon PA, Sekeres M, Hoey J, Lexchin J, Ferris LE, Moher D, Wu W, Kalkar SR, Van Laethem M, Gruneir A, Gold J, Maskalyk J, Streiner DL, Taback N, Chan AW.

Trials. 2011 Jan 12;12:9. doi: 10.1186/1745-6215-12-9.

50.

Reporting of methodologic information on trial registries for quality assessment: a study of trial records retrieved from the WHO search portal.

Reveiz L, Chan AW, Krleza-Jerić K, Granados CE, Pinart M, Etxeandia I, Rada D, Martinez M, Bonfill X, Cardona AF.

PLoS One. 2010 Aug 31;5(8):e12484. doi: 10.1371/journal.pone.0012484.

Supplemental Content

Loading ...
Support Center